ACAD — ACADIA PHARMACEUTICALS INC

Ownership history in Scientech Research LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Scientech Research LLC reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.28% (2025 Q3)
Avg. % of fund
0.16%
First filed
2024 Q2
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 37,558 -227 -0.6% 0.28% $801K $21.34
2025 Q1 ADDED 37,785 +27,384 +263.3% 0.17% $628K $16.61
2024 Q4 REDUCED 10,401 -31,185 -75.0% 0.05% $191K $18.35
2024 Q2 INITIATED 41,586 — — 0.14% $676K —
% of Fund (quarterly)    ACAD price (monthly, adj. close)

Other funds also holding ACAD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 9.24% BAKER BROS. ADVISORS LP 3Y 7Y 6.71% Birchview Capital, LP 3Y 7Y 2.67% Nan Fung Group Holdings Ltd 3Y 2.46% Axecap Investments, LLC 2.25% Stonepine Capital Management, LLC 3Y 7Y 1.95% RTW INVESTMENTS, LP 3Y 7Y 1.91% BRAIDWELL LP 3Y 1.74% Logos Global Management LP 3Y 1.37% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.1%
← Back to Scientech Research LLC Holdings